Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs

The development of targeted therapies has revolutionized cancer treatment, offering improved efficacy with reduced side effects compared with traditional chemotherapy. This review highlights the current landscape of targeted therapy in lung cancer, colorectal cancer, and prostate cancer, focusing on...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ha Yeong, Chang, Ji-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487969/
https://www.ncbi.nlm.nih.gov/pubmed/37686423
http://dx.doi.org/10.3390/ijms241713618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487969/
https://www.ncbi.nlm.nih.gov/pubmed/37686423
http://dx.doi.org/10.3390/ijms241713618

Ejemplares similares